Autoimmune thyroiditis - selected etiopathogenic mechanisms

Česká verzia

Authors: I. Šterzl ^1,2; P. Hrdá ^1,2; P. Matucha ¹; B. Potužníková ²; J. Procházková ³
Authors place of work: Endokrinologický ústav, Praha, ředitel doc. MUDr. Vojtěch Hainer, CSc. ¹; Ústav imunologie a mikrobiologie 1. lékařské fakulty UK a VFN, Praha, přednosta doc. MUDr. Ivan Šterzl, CSc. ²; Stomatologický ústav 1. lékařské fakulty UK a VFN, Praha, přednosta prof. MUDr. J. Dušková, DrSc., MBA ³
Published in the journal: Vnitř Lék 2006; 52(10): 891-899
Category: Original Contributions

Summary

Autoimmune thyroiditis occurs as organ specific autoimmune disease not only as an isolated impairment of thyroid gland, but also linked to many autoimmune endocrinopathies. Genetic predisposition in the area of HLA antigens was followed up for patients with autoimmune thyroiditis diagnosed in this way and it appeared that genetic predisposition in isolated autoimmune thyroiditis is different when compared to the occurrence linked to endocrine polyglandular disease. In selected groups of patients with autoimmune disease also the influence of extraneous factors on the development of the autoimmune process was followed up, namely the influence of heavy metals and the influence of infectious agent - Helicobacter pylori. Also these factors have a different character of activation of autoimmune thyroiditis, depending on the character of its manifestation as isolated disorder or in link to autoimmune polyglandular syndrome type II, or in link to the group of polyglandular activation of autoimmunity. To conclude, this study leads to the assumption, that autoimmune thyroiditis is a set of clinical syndromes that depends on the activation of the autoimmune process, rather than a strictly genetically and epigenetically characterized nosological unit.

Keywords:
autoimmune thyroiditis - autoimmune polyglandular syndrome - polyglandular activation of autoimmunity - HLA antigens - Helicobacter pylori - heavy metals

Zdroje

1. Muir A, Schatz DA, Maclaren NK. Polyglandular failure syndromes. 3013-3022. In: DeGroot LJ, Besser M, Burger HG. Endocrinology. Philadelphia: WB Saunders 1995: 3013-3022.

2. Šterzl I, Fučíková T, Hrdá P et al. Únavový syndrom u autoimunitní tyreoiditidy s polyglandulární aktivací autoimunity. Vnitř Lék 1998; 44: 456-460.

3. Šterzl I, Vavrejnová V, Matucha P et al. Extrathyroid autoantibodies in autoimmune thyroiditis. Polyendocrine autoantibodies. The Thyroid Gland 1999; 2: 37-43.

4. Volpé R. The immunology of human autoimmune thyroid disease. 217-245. In: Volpé R. Autoimmune endocrinopathies. New Jersey 1999. 217-245.

5. Wucherpfennig KW, Strominger JL. Selective binding of self peptides to disease-associated major histocompatibility complex (MHC) molecules: a mechanism for MHC-linked susceptibility to human autoimmune diseases. J Exp Med 1995; 181: 1597-1601.

6. Zamrazil V, Němec J, Šterzl I. Autoimunitní tyreopatie. Klinická biochemie a metabolismus 1995; 3: 71-73.

7. Robles DT, Fain PR, Gottlieb PA et al. The genetics of autoimmune polyendocrine syndrome type II. Endocrinol Metab Clin North Am 2002; 31: 353-368.

8. Wallaschofski H, Meyer A, Tuschy U et al. HLA-DQA1*0301-associated susceptibility for autoimmune polyglandular syndrome type II and III. Horm Metab Res 2003; 35: 120-124.

9. De Maria R, Testi R. Fas-FasL interactions: a common pathogenetic mechanism in organ-specific autoimmunity. Immunol Today 1998; 19: 121-125.

10. Ban Y, Tomer Y. Genetic susceptibility in thyroid autoimmunity. Pediatr Endocrinol Rev 2005; 3: 20-32.

11. Gianani R, Sarvetnick N. Viruses, cytokines, antigens, and autoimmunity. Proc Natl Acad Sci USA 1996; 93: 2257-2259.

12. Tomer Y, Davies TF. Infection, thyroid disease, and autoimmunity. Endocr Rev 1993; 14: 107-120.

13. Bech K, Clemmensen O, Larsen JH et al. Thyroid disease and Yersinia. Lancet 1977; 8020: 1060-1061.

14. de Luis DA, Varela C, de La Calle H et al. Helicobacter pylori infection is markedly increased in patients with autoimmune atrophic thyroiditis. J Clin Gastroenterol 1998; 26: 259-263.

15. De Koster E, De Bruyne I, Langlet P et al. Evidence based medicine and extradigestive manifestations of Helicobacter pylori. Acta Gastroenterol Belg 2000; 63: 388-392.

16. Bertalot G, Montresor G, Tampieri M et al. Decrease in thyroid autoantibodies after eradication of Helicobacter pylori infection. Clin Endocrinol (Oxf) 2004; 61: 650-652.

17. Larizza D, Calcaterra V, Martinetti M et al. Helicobacter pylori infection and autoimmune thyroid disease in young patients: the disadvantage of carrying the human leukocyte antigen-DRB1*0301 allele. J Clin Endocrinol Metab 2006; 91: 176-179.

18. Tomasi PA, Dore MP, Fanciulli G et al. Is there anything to the reported association between Helicobacter pylori infection and autoimmune thyroiditis? Dig Dis Sci 2005; 50: 385-388.

19. Bruce GJ, Hall WB. Nickel hypersensitivity-related periodontitis. Compend Contin Educ Dent 1995; 178(16): 180-174.

20. Eti S, Weisman R, Hoffman R et al. Slight renal effect of mercury from amalgam fillings. Pharmacol Toxicol 1995; 76: 47-49.

21. Hanf V, Forstmann A, Costea JE et al. Mercury in urine and ejaculate in husbands of barren couples. Toxicol Lett 1996; 88: 227-231.

22. Hensten-Pettersen A. Casting alloys: side-effects. Adv Dent Res 1992; 6: 38-43.

23. Larsson A, Warfvinge G. The histopathology of oral mucosal lesions associated with amalgam or porcelain-fused-to-metal restorations. Oral Dis 1995; 1: 152-158.

24. Selden AI, Persson B, Bornberger-Dankvardt SI et al. Exposure to cobalt chromium dust and lung disorders in dental technicians. Thorax 1995; 50: 769-772.

25. Shitova O, Guseva L, Denisova A et al. Immunosupression caused by industrial chemicals in workers of a pharmaceutical factory. In: Abstracts of the 8th International Congress of Immunology. Budapest (Hungary), Aug 1992. Budapest (Hungary): Springer Hungarica 1992: 597.

26. Ionescu G. Allergotoxische Einflüsse von Umweltschadstoffen bei Allergiekranken. Forsch Komplementärmed 1995; 2: 2-8.

27. Skare I, Bergstrom T, Engqvist A et al. Mercury exposure of different origins among dentists and dental nurses. Scand J Work Environ Health 1990; 16: 340-347.

28. Sterzl I, Prochazkova J, Hrda P et al. Mercury and nickel allergy: risk factors in fatigue and autoimmunity. Neuroendocrinol Lett 1999; 20: 221-228.

29. R Development. Core Team. R: A language and environment for statistical computing. Vienna: R Foundation for Statistical Computing; 2005.

30. Figura N, Di Cairano G, Lore F et al. The infection by Helicobacter pylori strains expressing CagA is highly prevalent in women with autoimmune thyroid disorders. J Physiol Pharmacol 1999; 50: 817-826.

31. Raymond J, Sauvestre C, Kalach N et al. Immunoblotting and serology for diagnosis of Helicobacter pylori infection in children. Pediatr Infect Dis J 2000; 19: 118-121.

32. Moran AP, Prendergast MM, Appelmelk BJ. Molecular mimicry of host structures by bacterial lipopolysaccharides and its contribution to disease. FEMS Immunol Med Microbiol 1996; 16: 105-115.

33. Negrini R, Savio A, Poiesi C et al. Antigenic mimicry between Helicobacter pylori and gastric mucosa in the pathogenesis of body atrophic gastritis. Gastroenterology 1996; 111: 655-665.

34. Roos A, Schilder-Tol EJ, Chand MA et al. HgCl2 and IL4 differentially modify expression of major histocompatibility complex class II molecules RT1.B and RT1.D in B lymphocytes from brown Norway and Lewis rats. Transplant Proc 1997; 29: 1675-1676.